CAS 62568-57-4
:trp-ala-gly-gly-asp-ala-ser-gly-glu
- Emideltide
- L-tryptophyl-L-alanylglycylglycyl-L-alpha-aspartyl-L-alanyl-L-serylglycyl-L-glutamic acid
- Tryptophylalanylglycylglycyl-Alpha-Aspartylalanylserylglycylglutamic Acid
- Dsip
δ-Sleep Inducing Peptide
CAS :Bachem ID: 4033012.
Formule :C35H48N10O15Degré de pureté :96.2%Couleur et forme :White LyophilisateMasse moléculaire :848.82DSIP
CAS :Formule :C35H48N10O15Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :848.8136δ-Sleep Inducing Peptide
CAS :δ-Sleep Inducing PeptideDegré de pureté :≥90%Masse moléculaire :848.81g/molδ-Sleep Inducing Peptide
CAS :δ-Sleep Inducing Peptide (DSIP) is a neuropeptide, with antioxidant and anxiolytic properties.Formule :C35H48N10O15Degré de pureté :92.36%Couleur et forme :SolidMasse moléculaire :848.81Delta Sleep-Inducing Peptide [DSIP]
CAS :Delta Sleep-Inducing Peptide (DSIP) is a neuropeptide that induces delta sleep in mammals. Studies have shown that DSIP plasma concentrations and the human circadian rhythm are correlated and that DSIP concentrations are dependent on the initiation of sleep. Interestingly DSIP has the ability to cross the blood-brain barrier and can be absorbed from the gut. This neuropeptide is found in plasma, peripheral organs and neurons and its functions extend beyond inducing sleep. For example it has the ability to affect levels of hormones, neurotransmitters and psychological performance. It has also been found that schizophrenia and depression patients have lower concentrations of DSIP in their cerebrospinal fluid and plasma. Clinically DFSIP has already been used to treat opioid and alcohol withdrawal in reducing symptoms felt by patients.
Formule :C35H48N10O15Degré de pureté :Min. 95%Masse moléculaire :848.82 g/molδ Sleep-Inducing Peptide (DSIP)
CAS :The Delta Sleep-Inducing Peptide (DSIP) is a neuropeptide which is found in plasma, peripheral organs and neurons. It has been found to induce delta sleep in mammals and have the ability to cross the blood-brain barrier as well as be absorbed from the gut. Studies have shown that DSIP plasma concentration and the human circadian rhythm are correlated and that DSIP concentrations are dependent on the initiation of sleep. DSIP has also demonstrated its ability to affect levels of hormones, neurotransmitters and psychological performance. In patients with schizophrenia and depression levels of DSIP in the cerebrospinal fluid and plasma were found to be lower compared to healthy controls. Clinically DFSIP has already been used to treat opioid and alcohol withdrawal in reducing symptoms felt by patients. This product is available as a 0.5mg vial.Formule :C35H48N10O15Degré de pureté :Min. 95%Masse moléculaire :848.81 g/molDelta-Sleep Inducing Peptide trifluoroacetate salt
CAS :Delta-Sleep Inducing Peptide trifluoroacetate salt H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH trifluoroacetate salt is a peptide that has been shown to have a hypnotic effect in mice. It was found to increase the time spent on the rotarod and decrease locomotor activity in mice. This drug has also been shown to be hypoglycemic and to modulate transcriptional regulation of fatty acid metabolism. Delta Sleep Inducing Peptide trifluoroacetate salt H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly Gly Glu OH trifluoroacetate salt may be useful in treating autoimmune diseases, such as multiple sclerosis, due to its ability to regulate 5HT concentrations.
Formule :C35H48N10O15Masse moléculaire :848.81 g/mol





